Basta James Insider Trades

Insider Trading History

Track insider trading activity for Basta James. See latest buy and sell transactions across all companies.

Holdings

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price

Insider Trades History

Company
Holding Value
Last Transaction
Sale/Purchase
Amount
Price
Current Price
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $2.04M 156,794 shares
Last Trade
Mar 02, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$18.7k 1,211 shares
$15.44
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $2.06M 158,005 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$635k 46,080 shares
$13.78
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $857k 65,829 shares
Last Trade
Mar 01, 2026 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$907k 65,829 shares
$13.78
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $1.32M 101,528 shares
Last Trade
Jan 05, 2026 Sale (Open Market)Shares sold on the open market or in a private sale.
$95.8k 10,397 shares
$9.21
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $1.46M 111,925 shares
Last Trade
Mar 04, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$23.1k 2,572 shares
$8.99
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $1.49M 114,497 shares
Last Trade
Mar 01, 2025 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$577k 57,143 shares
$10.09
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $970k 74,497 shares
Last Trade
Jan 03, 2025 Sale (Open Market)Shares sold on the open market or in a private sale.
$86.2k 7,074 shares
$12.18
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $1.06M 81,571 shares
Last Trade
Mar 04, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$75.8k 2,297 shares
$32.99
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $1.09M 83,868 shares
Last Trade
Mar 01, 2024 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.53M 46,752 shares
$32.66
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $670k 51,474 shares
Last Trade
Jan 03, 2024 Sale (Open Market)Shares sold on the open market or in a private sale.
$112k 3,805 shares
$29.46
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $720k 55,279 shares
Last Trade
Mar 02, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$47.7k 1,088 shares
$43.88
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $734k 56,367 shares
Last Trade
Mar 01, 2023 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.41M 34,674 shares
$40.75
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $255k 19,559 shares
Last Trade
Jan 04, 2023 Sale (Open Market)Shares sold on the open market or in a private sale.
$42.3k 1,138 shares
$37.21
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $184k 14,109 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$1.13M 14,109 shares
$79.85
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $126k 9,648 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$770k 9,648 shares
$79.85
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $269k 20,697 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$770k 9,648 shares
$79.85
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $144k 11,049 shares
Last Trade
Mar 01, 2022 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$882k 11,049 shares
$79.85
$13.02
Intellia Therapeutics
Intellia Therapeutics NTLA
Evp, General Counsel
Holding Value $1.69M 130,000 shares
Last Trade
Jul 01, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$22.3M 130,000 shares
$171.65
$13.02
Kura Oncology
Kura Oncology KURA
Chief Legal Officer
Holding Value $1.08M 125,000 shares
Last Trade
Jan 26, 2021 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$4.1M 125,000 shares
$32.80
$8.66
Kura Oncology
Kura Oncology KURA
Chief Legal Officer
Holding Value $216k 25,000 shares
Last Trade
Mar 12, 2020 Purchase (Award)Shares received as a grant, bonus, or other company award rather than an open-market purchase.
$210k 25,000 shares
$8.41
$8.66

See more insider trades for free

Join Stockcircle to see more insider trades and be the first to know about new executive transactions.

Sign Up